Poly-acetylated chromatin signatures are preferred epitopes for site-specific histone H4 acetyl antibodies. 2012

Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Antibodies specific for histone post-translational modifications (PTMs) have been central to our understanding of chromatin biology. Here, we describe an unexpected and novel property of histone H4 site-specific acetyl antibodies in that they prefer poly-acetylated histone substrates. By all current criteria, these antibodies have passed specificity standards. However, we find these site-specific histone antibodies preferentially recognize chromatin signatures containing two or more adjacent acetylated lysines. Significantly, we find that the poly-acetylated epitopes these antibodies prefer are evolutionarily conserved and are present at levels that compete for these antibodies over the intended individual acetylation sites. This alarming property of acetyl-specific antibodies has far-reaching implications for data interpretation and may present a challenge for the future study of acetylated histone and non-histone proteins.

UI MeSH Term Description Entries
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D042002 Chromatin Assembly and Disassembly The mechanisms effecting establishment, maintenance, and modification of that specific physical conformation of CHROMATIN determining the transcriptional accessibility or inaccessibility of the DNA. Chromatin Remodeling,Chromatin Assembly,Chromatin Disassembly,Chromatin Modeling,Chromatin Disassemblies,Disassembly, Chromatin,Remodeling, Chromatin
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics

Related Publications

Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
December 1993, Biochemistry,
Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
August 1978, Proceedings of the National Academy of Sciences of the United States of America,
Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
February 1980, FEBS letters,
Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
January 2014, PloS one,
Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
February 2012, The Journal of biological chemistry,
Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
April 1992, Cell,
Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
April 1996, Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology,
Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
May 2009, Journal of the American Chemical Society,
Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
November 1999, Methods (San Diego, Calif.),
Scott B Rothbart, and Shu Lin, and Laura-Mae Britton, and Krzysztof Krajewski, and Michael-C Keogh, and Benjamin A Garcia, and Brian D Strahl
January 2009, F1000 biology reports,
Copied contents to your clipboard!